The Application Notebook
For your highly sensitive UHPLC–MS analyses, how can you reduce noise and additional signals to a minimum?
For your highly sensitive UHPLC–MS analyses, how can you reduce noise and additional signals to a minimum? Our new high-end UHPLC–MS solvents raise the standard for low baseline noise and clean mass spectra.
Our new range of advanced UHPLC–MS LiChrosolv® solvents have been developed to exceed all expectations, providing rapid and reliable results in both ESI/APCI positive and negative ionization modes.
Thanks to their lowest level of background noise and ion suppression, this quality ensures the optimum ionization efficiency to enable the highest sensitivity. With these features, use of these solvents can also help to extend column lifetime.
To ensure that you have confidence in your results, we specify the lowest possible limit of polyethylene glycol (PEG) impurities in all our UHPLC–MS solvents.
Our advanced UHPLC–MS LiChrosolv solvents have been designed to meet the highest requirements of UHPLC–MS in research and quality control, including proteomics and metabolomics, as well as environmental, clinical, food, or industrial testing applications.
A new standard for the unlimited application of ultrahigh-pressure chromatography has been set.
Features and Benefits
LiChrosolv methanol for UHPLC–MS shows a flat baseline and by far the lowest impurity profile compared to the competition. Both competitor’s high purity UHPLC–MS products A and B show a baseline drift and significant impurity peaks.
Test 1: UHPLC–MS gradient run with LiChrosolv acetonitrile for UHPLC–MS shows a clear detection and identification of 1 ppb reserpine, 500 ppt propazine, and 4 ppb prednisolone, with very low background interferences.
Test 2: Comparison of LiChrosolv methanol for UHPLC–MS (blue line) with two competitor UHPLC–MS products.
To read the rest of this application please visit SigmaAldrich.com/UHPLC–MS.
Merck
Frankfurter Strasse 250
Darmstadt, 64293, Germany
Website: www.sigmaaldrich.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.